SuperworthWestlake Chemical Partners WLKP
- Market cap
- $745.5M
- PE
- 13.0×
- 10y median 13.7×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.6×
- EV/EBIT
- 3.1×
- Revenue, 12 months
- $1.2B
- +12% on a year ago
- Net margin
- 4.7%
- Free cash flow yield
- n/m
- a yield above 40% (usually a one-off)
Westlake Chemical Partners trades at 13.0× trailing earnings, cheaper than 69% of the last ten years. Revenue was $1.2B over the last twelve months, up 12% on a year earlier with a 5% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $321.7M−23% | $297.3M−19% | $284.7M−8% | $284.2M+8% | $277M−14% | $290.1M−2% | $237.6M−17% | $297.1M+5% | $308.9M+12% | $323M+11% | $305.7M+29% | $297.1M+0% | |
| Cost of revenue | $228.7M−30% | $196.6M−27% | $182.5M−10% | $182.9M+4% | $160.1M−30% | $191.5M−3% | $183.5M+1% | $199.6M+9% | $209.5M+31% | $226.2M+18% | $211.9M+16% | $202.3M+1% |
| Gross profit | $93M+3% | $100.7M+3% | $102.2M−4% | $101.2M+15% | $116.9M+26% | $98.6M−2% | $54.1M−47% | $97.5M−4% | $99.4M−15% | $96.8M−2% | $93.8M+73% | $94.8M−3% |
| SG&A | $6.7M−22% | $7.9M+176% | $7.1M−11% | $7.6M+5% | $7.3M+8% | $6.6M−17% | $7.5M+6% | $6.3M−17% | $7.4M+3% | $7.1M+8% | $7.2M−4% | $7.5M+19% |
| $86.2M+5% | $92.8M−3% | $95.1M−3% | $93.6M+16% | $109.7M+27% | $92M−1% | $46.6M−51% | $91.2M−3% | $92M−16% | $89.8M−3% | $86.6M+86% | $87.3M−4% | |
| Interest expense | n/a | n/a | $6.6M | $6.7M | $6.7M | $5.8M | $5.5M−16% | $5.9M−11% | $5.9M−11% | $5.5M−5% | $5.1M−8% | $5.1M−13% |
| Pre-tax income | $81.1M+3% | $87.3M−5% | $89.9M−2% | $88.2M+17% | $104.3M+29% | $87.6M+0% | $42.4M−53% | $86M−3% | $86.3M−17% | $84.5M−4% | $81.8M+93% | $82.5M−4% |
| $222K−54% | $206K+6% | $210K−1% | $207K+20% | $216K−3% | $202K−2% | $107K−49% | $205K−1% | $42K−81% | $193K−5% | $177K+65% | $178K−13% | |
| Net income | $13.2M−11% | $14.3M−15% | $14.8M−0% | $14.4M+21% | $18.1M+37% | $15M+5% | $4.9M−67% | $14.6M+1% | $14.7M−19% | $14.5M−3% | $14.2M+186% | $14.2M−2% |
| $0.37−12% | $0.41−15% | $0.42+0% | $0.41+21% | $0.51+38% | $0.43+5% | $0.14−67% | $0.41+0% | $0.42−18% | $0.41−5% | $0.40+186% | $0.40−2% | |
| 35.2M+0% | 35.2M+0% | 35.2M+0% | 35.2M+0% | 35.2M+0% | 35.2M+0% | 35.2M+0% | 35.2M+0% | 35.2M+0% | 35.2M+0% | 35.2M+0% | 35.2M+0% |
Revenue: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
SG&A: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
Operating income: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
Income tax: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
Net income: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
EPS, diluted: 43 periods, Q4 FY15 to Q2 FY26: quarter's net income to common over its shares, to the cent.
Diluted shares: 11 periods, Q4 FY15 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Chemicals - Specialty nearest Westlake Chemical Partners' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| WLKPWestlake Chemical Partners | $745.5M | 13.0× | 13.7× | 0.6× | +12% | 4.7% | |
| LXULSB Industries | $712.1M | 19.8× | 7.9× | 1.1× | +22% | 5.6% | |
| GPREGreen Plains | $979.9M | 8.8× | 26.1× | 0.5× | −24% | 6.8% | |
| LXFRLuxfer | $462.4M | 59.6× | 22.4× | 1.3× | −11% | 2.2% | |
| REXREX AMERICAN RESOURCES | $1.3B | 10.9× | 16.8× | 2.0× | +1% | 19.7% | |
| ALTOAlto Ingredients | $280M | 5.4× | 13.8× | 0.3× | +1% | 5.5% | |
| SXTSensient Technologies | $5.6B | 35.8× | 29.8× | 3.3× | +8% | 9.3% | |
| AXTAAxalta Coating Systems | $7.3B | 21.1× | 28.3× | 1.4× | −1% | 6.8% | |
| Peer median | $979.9M | 19.8× | 22.4× | 1.3× | +1% | 6.8% |
More on Westlake Chemical Partners
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #2of 106Materials stocks with the lowest EV/EBIT
- #1of 21Specialty chemicals stocks with the lowest EV/EBIT
- #5of 29Specialty chemicals stocks with the fastest revenue growth
- #7of 32Specialty chemicals stocks with the lowest price to sales ratio
- #4of 16Specialty chemicals stocks with the lowest PE ratio
- #5of 12Specialty chemicals stocks with the fastest earnings growth
- #7of 13Specialty chemicals stocks cheapest against their own PE history
Its groups
About
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .